Topics

Idiopathic Intracranial Hypertension May Double CV Risk

08:05 EDT 12 Jul 2019 | Medscape

Results of a new study suggest that idiopathic intracranial hypertension appears to be a systemic metabolic condition conferring a sizable increase in cardiovascular risk.
Medscape Medical News

Original Article: Idiopathic Intracranial Hypertension May Double CV Risk

NEXT ARTICLE

More From BioPortfolio on "Idiopathic Intracranial Hypertension May Double CV Risk"

Quick Search

Relevant Topics

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...